Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,965 public trials 2,022 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

NCT05253495

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations: University of Alabama Birmingham, Alabama, United States

University of Flordia Gainsville, Florida, United States

New York Medical College Vallhala, New York, United States

View Trial Details

Recruiting

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

NCT06830031

Conditions: DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell-lymphoma, +22 more
Locations: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

NCT06409702

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques

NCT04417803

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Chu Dijon Bourgogne Dijon, France

View Trial Details

Recruiting

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT05219721

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study

NCT04957901

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Yizhuo Zhang Guangzhou, China

View Trial Details

Recruiting

Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations

NCT07012447

Conditions: Digestive System Diseases, Early T Acute Lymphoblastic Leukemia, Gastric Outlet Obstruction, +19 more
Locations: Ethical Committee of the First Affliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

NCT06940960

Conditions: B Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma, Burkitt Lymphoma, +16 more
Locations: Affiliated Hospital of Guangdong Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

NCT06257394

Conditions: Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Seoul National University Hospital Seoul, South Korea

Severance Hospital Seoul, South Korea

Asan Medical Center Seoul, South Korea

Samsung Medical Center Seoul, South Korea

View Trial Details

Recruiting

Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia

NCT06184009

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Seoul National University Hospital Seoul, South Korea

Samsung Medical Center Seoul, South Korea

Korea University Anam Hospital Seoul, South Korea

Severance Hospital Seoul, South Korea

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions